Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Dryden-Peterson, Scott	Brigham And Women'S Hospital United States	Botswana CASCADE Clinical Trials Site	3UG1CA275416-04S1	Maria Silvina Frech, Ph.D., M.S.
Duan, Bin	University Of Nebraska Medical Center United States	Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain	1R21CA298918-01	Rachel Altshuler, Ph.D.
Duncavage, Eric J	Washington University United States	Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes	4UH3CA272904-02	Nicholas Hodges, Ph.D.
Duvall, Adam S.	University Of Chicago United States	Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant	1R34CA297498-01	Brennan Streck, Ph.D., RN, M.P.H.
Eastham, James A	Sloan-Kettering Inst Can Research United States	Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers	5U01CA266535-04	Claire Zhu, Ph.D.
Eibl, Guido Erwin Michael	University Of California Los Angeles United States	Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma	5P01CA236585-05
Eickhoff, Jens	University Of Wisconsin-Madison United States	CP-CTNet Coordinating Center	1UG1CA304955-01	Donald Johnsey
Eisenmann, Eric Daniel	Ohio State University United States	Damage-associated molecular patterns in chemotherapy toxicity	1R37CA299879-01	Rachel Altshuler, Ph.D.
El-Bayoumy, Karam E	Pennsylvania State Univ Hershey Med Ctr United States	Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies	5R01CA173465-10	Gabriela Riscuta, M.D., CNS
El-Serag, Hashem B	Baylor College Of Medicine United States	Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome	5P01CA263025-04	Asad Umar, D.V.M., Ph.D.
Eldridge, Ronald C	Emory University United States	Integrative Multi-Omics of Metabolomics and Epigenetics to Explore thePathophysiology of Cachexia and Survival in Head and Neck SquamousCell Carcinoma	1R03CA304028-01	Marjorie Perloff, M.D.
Elenitoba-Johnson, Kojo S. J.	Sloan-Kettering Inst Can Research United States	Genomic biomarkers of splenic lymphoma	5R01CA255655-06	Nicholas Hodges, Ph.D.
Elias, Kevin	Cleveland Clinic Lerner Com-Cwru United States	Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness	7R03CA283252-02	Christos Patriotis, Ph.D., M.Sc.
Ellerton, John A	Southern Nevada Cancer Research Fdn United States	NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)	3UG1CA189829-11S1	Vanessa A. White, M.P.H.
Ellsworth, Grant B.	Weill Medical Coll Of Cornell Univ United States	Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico	3U54CA242639-06S3	Maria Silvina Frech, Ph.D., M.S.